Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rat polymeric IgA binds C1q, but does not activate C1.

P S Hiemstra1, M Rits, A Gorter

  • 1Department of Nephrology, University Hospital Leiden, The Netherlands.

Molecular Immunology
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticorps Monoclonaux: Principes Fondamentaux Et Applications.

Acta clinica Belgica·2016
Same author

The lymphocytes of splenic marginal zones: a distinct B-cell lineage.

Immunology today·2014
Same author

More on rat monoclonal antibodies.

Immunology today·2014
Same author

Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma.

International journal of cancer·2013
Same author

Role of IL-12p40 in cervical carcinoma.

British journal of cancer·2012
Same author

CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.

British journal of cancer·2012

Polymeric IgA (p-IgA) immune complexes inhibit the classical complement pathway by binding C1q, preventing C1 activation and immune precipitation. This interaction modulates complement-mediated reactions.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Immune complexes activate the alternative complement pathway.
  • The interaction of IgA immune complexes with the classical complement pathway remains less understood.

Purpose of the Study:

  • To investigate how monoclonal IgA antibodies interact with the classical complement pathway.
  • To determine the mechanism by which polymeric IgA (p-IgA) modulates classical pathway activation.

Main Methods:

  • Investigated inhibition of IgG2b-mediated lysis of antibody-coated red blood cells by p-IgA.
  • Assessed C3 binding to IgG2b immune complexes in the presence of p-IgA.
  • Studied the interaction of p-IgA with C1q and C1 components.

Main Results:

Related Experiment Videos

  • Polymeric IgA (p-IgA) inhibited IgG2b-mediated classical complement pathway lysis and C3 deposition.
  • p-IgA, but not monomeric IgA, bound to both rat and human C1q via its globular heads.
  • p-IgA binding to C1q did not activate C1, unlike IgG2b binding.
  • Formation of insoluble p-IgA immune complexes was inhibited by serum or C1.

    • Conclusions:

    • p-IgA binds C1q through its globular heads, modulating classical complement pathway activation.
    • This interaction inhibits C1 activation and subsequent immune precipitation.
    • p-IgA plays a regulatory role in classical complement-mediated immune responses.